Dr. Marwan Suleman Shinawi, MD

Dr. Shinawi practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Shinawi's NPI, 1912087354, was assigned on October 17, 2006. Dr. Shinawi graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1996. Dr. Shinawi holds Missouri license 2009029458.

Dr. Shinawi's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Shinawi also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Shinawi's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shinawi practices. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Shinawi's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Shinawi is board certified in clinical genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Shinawi's licenses on file in 3 states: Missouri, Illinois and Texas.

CMS data shows 12 Medicare services from Dr. Shinawi across 1 procedure code in 2019, all of them office visits, for 13 Medicare patients. Medicare paid $1,255 for them. Every service was in an office.

CMS counts 13 Medicare patients who saw Dr. Shinawi in 2024. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shinawi's median patient age at 15, with 50% women.

In 2024, Dr. Shinawi wrote 23 Medicare Part D claims. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $405,956 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Shinawi for performance year 2024, reported as part of a group. Dr. Shinawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shinawi as offering telehealth.

Dmand AI links 226 papers to Dr. Shinawi, published from 2004 to 2025. 2019 was the busiest year, with 17. The most frequent topics are Phenotype, Intellectual Disability and Pedigree. Dr. Shinawi has published most often in Am J Med Genet A. Dr. Shinawi's most frequent co-authors are Arthur Beaudet, MD, James Lupski, MD, PhD and Dorothy K. Grange, MD.

Dmand AI links Dr. Shinawi to 1 clinical trial. Conditions studied include Ornithine Carbamoyltransferase Deficiency Disease and Urea Cycle Disorders, Inborn.

CMS Open Payments shows 7 general payments to Dr. Shinawi from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Horizon Pharma plc paid the most, $120.

Dr. Shinawi graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1996. Dr. Shinawi is a member of American College of Medical Genetics, AMA and American Society of Human Genetics.

Dr. Shinawi is in network with 19 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.